FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3131200142> ?p ?o ?g. }

• W3131200142 endingPage "778" @default.
• W3131200142 startingPage "770" @default.
• W3131200142 abstract "Lipid nanocarriers have been widely tested as drug delivery systems to treat diseases due to their bioavailability, controlled release, and low toxicity. For the pulmonary route, the Food and Drug Administration favors the use of substances generally recognized as safe, as well as biodegradable and biocompatible to minimize the possibility of toxicity. Tuberculosis (TB) remains a public health threat worldwide, mainly due to the long treatment duration and adverse effects. Therefore, new drug delivery systems for treating TB are needed.Physicochemical characterization of different lipid-based nanocarriers was used to optimize carrier properties. Optimized systems were incubated with Mycobacterium tuberculosis to assess whether lipid-based systems act as the energy source for the bacteria, which could be counterproductive to therapy.Several excipients and surfactants were evaluated to prepare different types of nanocarriers using high-pressure homogenization.A mixture of trimyristin with castor oil was chosen as the lipid matrix after differential scanning calorimetry analysis. A mixture of egg lecithin and PEG-660 stearate was selected as an optimal surfactant system, as this mixture formed the most stable formulations. Three types of lipid nanocarriers, solid lipid nanoparticles, nanostructured lipid carriers (NLC), and nanoemulsions, were prepared, with the NLC systems showing the most suitable properties for further evaluation. It may provide the advantages of increasing the entrapment efficiency, drug release, and the ability to be lyophilized, producing powder for pulmonary administration as an alternative to entrap poor water-soluble molecules.Furthermore, the NLC system can be considered for use as a platform for the treatment of TB through the pulmonary route." @default.
• W3131200142 created "2021-03-01" @default.
• W3131200142 creator A5009582214 @default.
• W3131200142 creator A5016754673 @default.
• W3131200142 creator A5017263799 @default.
• W3131200142 creator A5019017893 @default.
• W3131200142 creator A5023619500 @default.
• W3131200142 creator A5025016393 @default.
• W3131200142 creator A5027182196 @default.
• W3131200142 creator A5034360778 @default.
• W3131200142 creator A5047707424 @default.
• W3131200142 creator A5049166264 @default.
• W3131200142 creator A5049553650 @default.
• W3131200142 creator A5049851925 @default.
• W3131200142 creator A5063389304 @default.
• W3131200142 creator A5067246796 @default.
• W3131200142 creator A5090341182 @default.
• W3131200142 date "2021-09-20" @default.
• W3131200142 modified "2023-10-03" @default.
• W3131200142 title "Development of Lipid Nanocarriers for Tuberculosis Treatment: Evaluation of Suitable Excipients and Nanocarriers" @default.
• W3131200142 cites W1484126258 @default.
• W3131200142 cites W1687377681 @default.
• W3131200142 cites W1734250133 @default.
• W3131200142 cites W1970654452 @default.
• W3131200142 cites W1971988433 @default.
• W3131200142 cites W2016418766 @default.
• W3131200142 cites W2054189154 @default.
• W3131200142 cites W2078937040 @default.
• W3131200142 cites W2082865634 @default.
• W3131200142 cites W2085051997 @default.
• W3131200142 cites W2116128143 @default.
• W3131200142 cites W2117722565 @default.
• W3131200142 cites W2137397041 @default.
• W3131200142 cites W2159020941 @default.
• W3131200142 cites W2164757273 @default.
• W3131200142 cites W2322473086 @default.
• W3131200142 cites W2382177726 @default.
• W3131200142 cites W2525828717 @default.
• W3131200142 cites W2580524684 @default.
• W3131200142 cites W2599766179 @default.
• W3131200142 cites W2788744620 @default.
• W3131200142 cites W2889626807 @default.
• W3131200142 cites W2895996297 @default.
• W3131200142 cites W3011927243 @default.
• W3131200142 cites W3056563211 @default.
• W3131200142 cites W3093443397 @default.
• W3131200142 doi "https://doi.org/10.2174/1567201818666210212092112" @default.
• W3131200142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33583376" @default.
• W3131200142 hasPublicationYear "2021" @default.
• W3131200142 type Work @default.
• W3131200142 sameAs 3131200142 @default.
• W3131200142 citedByCount "2" @default.
• W3131200142 countsByYear W31312001422022 @default.
• W3131200142 countsByYear W31312001422023 @default.
• W3131200142 crossrefType "journal-article" @default.
• W3131200142 hasAuthorship W3131200142A5009582214 @default.
• W3131200142 hasAuthorship W3131200142A5016754673 @default.
• W3131200142 hasAuthorship W3131200142A5017263799 @default.
• W3131200142 hasAuthorship W3131200142A5019017893 @default.
• W3131200142 hasAuthorship W3131200142A5023619500 @default.
• W3131200142 hasAuthorship W3131200142A5025016393 @default.
• W3131200142 hasAuthorship W3131200142A5027182196 @default.
• W3131200142 hasAuthorship W3131200142A5034360778 @default.
• W3131200142 hasAuthorship W3131200142A5047707424 @default.
• W3131200142 hasAuthorship W3131200142A5049166264 @default.
• W3131200142 hasAuthorship W3131200142A5049553650 @default.
• W3131200142 hasAuthorship W3131200142A5049851925 @default.
• W3131200142 hasAuthorship W3131200142A5063389304 @default.
• W3131200142 hasAuthorship W3131200142A5067246796 @default.
• W3131200142 hasAuthorship W3131200142A5090341182 @default.
• W3131200142 hasConcept C13245373 @default.
• W3131200142 hasConcept C178790620 @default.
• W3131200142 hasConcept C181389837 @default.
• W3131200142 hasConcept C18150654 @default.
• W3131200142 hasConcept C185154212 @default.
• W3131200142 hasConcept C185592680 @default.
• W3131200142 hasConcept C199529486 @default.
• W3131200142 hasConcept C2779564620 @default.
• W3131200142 hasConcept C2779820397 @default.
• W3131200142 hasConcept C2780035454 @default.
• W3131200142 hasConcept C43617362 @default.
• W3131200142 hasConcept C55493867 @default.
• W3131200142 hasConcept C71924100 @default.
• W3131200142 hasConcept C98274493 @default.
• W3131200142 hasConceptScore W3131200142C13245373 @default.
• W3131200142 hasConceptScore W3131200142C178790620 @default.
• W3131200142 hasConceptScore W3131200142C181389837 @default.
• W3131200142 hasConceptScore W3131200142C18150654 @default.
• W3131200142 hasConceptScore W3131200142C185154212 @default.
• W3131200142 hasConceptScore W3131200142C185592680 @default.
• W3131200142 hasConceptScore W3131200142C199529486 @default.
• W3131200142 hasConceptScore W3131200142C2779564620 @default.
• W3131200142 hasConceptScore W3131200142C2779820397 @default.
• W3131200142 hasConceptScore W3131200142C2780035454 @default.
• W3131200142 hasConceptScore W3131200142C43617362 @default.
• W3131200142 hasConceptScore W3131200142C55493867 @default.
• W3131200142 hasConceptScore W3131200142C71924100 @default.
• W3131200142 hasConceptScore W3131200142C98274493 @default.

• next